{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:20:55Z","timestamp":1794262855298,"version":"4.9.0"},"reference-count":199,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1186\/s43141-021-00224-0","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T05:03:05Z","timestamp":1629522185000},"page":"123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":406,"title":["GABAA receptors: structure, function, pharmacology, and related disorders"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7153-2413","authenticated-orcid":false,"given":"Amr","family":"Ghit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-2528","authenticated-orcid":false,"given":"Dina","family":"Assal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-3883","authenticated-orcid":false,"given":"Ahmed S.","family":"Al-Shami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9428-3221","authenticated-orcid":false,"given":"Diaa Eldin E.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s43141-021-00224-0_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/08830738030180012101","article-title":"Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system","volume":"18","author":"Simeone","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1186\/s43141-021-00224-0_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.molmed.2011.03.003","article-title":"The contribution of GABAergic dysfunction to neurodevelopmental disorders","volume":"17","author":"Ramamoorthi","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1186\/s43141-021-00224-0_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2005.05.009","article-title":"GABA(A) receptor subtypes as targets for neuropsychiatric drug development","volume":"109","author":"Korpi","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1186\/s43141-021-00224-0_bib4","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1113\/jphysiol.2010.186999","article-title":"Mutations in GABAA receptor subunits associated with genetic epilepsies","volume":"588","author":"Macdonald","year":"2010","journal-title":"J Physiol"},{"key":"10.1186\/s43141-021-00224-0_bib5","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/npp.2011.108","article-title":"Genetic association of recovery from eating disorders: the role of GABA receptor SNPs","volume":"36","author":"Bloss","year":"2011","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10048-006-0045-1","article-title":"Investigation of autism and GABA receptor subunit genes in multiple ethnic groups","volume":"7","author":"Collins","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1186\/s43141-021-00224-0_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/433195","article-title":"Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism","volume":"77","author":"Ma","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1186\/s43141-021-00224-0_bib8","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1073\/pnas.1424958112","article-title":"Rare variants in neuronal excitability genes influence risk for bipolar disorder","volume":"112","author":"Ament","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1186\/s43141-021-00224-0_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA(B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1186\/s43141-021-00224-0_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of \u03b3-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1186\/s43141-021-00224-0_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pharmthera.2003.12.002","article-title":"GABAA receptors: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors","volume":"101","author":"Steiger","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1186\/s43141-021-00224-0_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-0186(99)00045-5","article-title":"Structure and subunit composition of GABA(A) receptors","volume":"34","author":"Sieghart","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1186\/s43141-021-00224-0_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001756-199312000-00026","article-title":"Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification","volume":"5","author":"Backus","year":"1993","journal-title":"Neuroreport"},{"key":"10.1186\/s43141-021-00224-0_bib14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1042\/BST0371399","article-title":"RNA editing and its impact on GABAA receptor function","volume":"37","author":"Daniel","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1186\/s43141-021-00224-0_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10571-005-4004-4","article-title":"Consequences of the evolution of the GABA(A) receptor gene family","volume":"25","author":"Darlison","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"10.1186\/s43141-021-00224-0_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0896-6273(90)90224-4","article-title":"The effect of subunit composition of rat brain GABAA receptors on channel function","volume":"5","author":"Sigel","year":"1990","journal-title":"Neuron"},{"key":"10.1186\/s43141-021-00224-0_bib17","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1073\/pnas.0400220101","article-title":"Positioning of the alpha-subunit isoforms confers a functional signature to gamma-aminobutyric acid type A receptors","volume":"101","author":"Minier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1186\/s43141-021-00224-0_bib18","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1186\/s43141-021-00224-0_bib19","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.febslet.2006.02.002","article-title":"A GABAA receptor of defined subunit composition and positioning: concatenation of five subunits","volume":"580","author":"Baur","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1186\/s43141-021-00224-0_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2006.04206.x","article-title":"GABAA receptor associated proteins: a key factor regulating GABAA receptor function","volume":"100","author":"Chen","year":"2007","journal-title":"J Neurochem"},{"key":"10.1186\/s43141-021-00224-0_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrn2370","article-title":"GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition","volume":"9","author":"Jacob","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.117.244673","article-title":"Genetic and molecular regulation of extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy","volume":"364","author":"Chuang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1186\/s43141-021-00224-0_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrn1496","article-title":"Molecular and neuronal substrates for general anaesthetics","volume":"5","author":"Rudolph","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156802611794863562","article-title":"A closer look at the high affinity benzodiazepine binding site on GABAA receptors","volume":"11","author":"Sigel","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1186\/s43141-021-00224-0_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fendo.2011.00044","article-title":"Neurosteroids and GABA-A receptor function","volume":"2","author":"Wang","year":"2011","journal-title":"Front Endocrinol"},{"key":"10.1186\/s43141-021-00224-0_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1186\/s43141-021-00224-0_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nn1469","article-title":"Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety","volume":"8","author":"Maguire","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2011.03.024","article-title":"GABAA receptor trafficking-mediated plasticity of inhibitory synapses","volume":"70","author":"Luscher","year":"2011","journal-title":"Neuron"},{"key":"10.1186\/s43141-021-00224-0_bib29","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1460-9568.2010.07473.x","article-title":"Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling","volume":"32","author":"Kasugai","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/2798","article-title":"Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin","volume":"1","author":"Essrich","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib31","doi-asserted-by":"crossref","first-page":"12860","DOI":"10.1073\/pnas.96.22.12860","article-title":"Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo","volume":"96","author":"Baer","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1186\/s43141-021-00224-0_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.08.017","article-title":"GABA, a natural immunomodulator of T lymphocytes","volume":"205","author":"Bjurst\u00f6m","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1186\/s43141-021-00224-0_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits","volume":"43","author":"Alam","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1186\/s43141-021-00224-0_bib34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hep.21562","article-title":"Decreased hepatocyte membrane potential differences and GABAA-beta3 expression in human hepatocellular carcinoma","volume":"45","author":"Minuk","year":"2007","journal-title":"Hepatology"},{"key":"10.1186\/s43141-021-00224-0_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/tice.2002.0217","article-title":"GABA in the endocrine pancreas: cellular localization and function in normal and diabetic rats","volume":"34","author":"Adeghate","year":"2002","journal-title":"Tissue Cell"},{"key":"10.1186\/s43141-021-00224-0_bib36","first-page":"L1206","article-title":"GABAA receptors are expressed and facilitate relaxation in airway smooth muscle","volume":"294","author":"Mizuta","year":"2008","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"10.1186\/s43141-021-00224-0_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0021-9258(19)50929-2","article-title":"gamma-Aminobutyric acid in brain: its formation from glutamic acid","volume":"187","author":"Roberts","year":"1950","journal-title":"J Biol Chem"},{"key":"10.1186\/s43141-021-00224-0_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1104\/pp.115.1.1","article-title":"The metabolism and functions of [gamma]-Aminobutyric acid","volume":"115","author":"Bown","year":"1997","journal-title":"Plant Physiol"},{"key":"10.1186\/s43141-021-00224-0_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2013.10.022","article-title":"Neurotransmitter release: the last millisecond in the life of a synaptic vesicle","volume":"80","author":"S\u00fcdhof","year":"2013","journal-title":"Neuron"},{"key":"10.1186\/s43141-021-00224-0_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/16604","article-title":"A homeostatic switch","volume":"397","author":"Miles","year":"1999","journal-title":"Nature"},{"key":"10.1186\/s43141-021-00224-0_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/DDDT.S62912","article-title":"Altered \u03b3-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants","volume":"9","author":"Pehrson","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1186\/s43141-021-00224-0_bib42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuint.2012.02.013","article-title":"Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control","volume":"61","author":"Rowley","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1186\/s43141-021-00224-0_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib45","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1007\/s12035-015-9423-8","article-title":"Tonic GABAA receptors as potential target for the treatment of temporal lobe epilepsy","volume":"53","author":"Schipper","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1186\/s43141-021-00224-0_bib46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature04404","article-title":"GABA regulates synaptic integration of newly generated neurons in the adult brain","volume":"439","author":"Ge","year":"2006","journal-title":"Nature"},{"key":"10.1186\/s43141-021-00224-0_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1460-9568.2011.07782.x","article-title":"Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis","volume":"34","author":"Duveau","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib48","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/hipo.22604","article-title":"Reduced tonic inhibition in the dentate gyrus contributes to chronic stress-induced impairments in learning and memory","volume":"26","author":"Lee","year":"2016","journal-title":"Hippocampus"},{"key":"10.1186\/s43141-021-00224-0_bib49","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1523\/JNEUROSCI.4209-09.2010","article-title":"Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory","volume":"30","author":"Martin","year":"2010","journal-title":"J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(82)91148-9","article-title":"Medullary ventral surface GABA receptors affect respiratory and cardiovascular function","volume":"248","author":"Yamada","year":"1982","journal-title":"Brain Res"},{"key":"10.1186\/s43141-021-00224-0_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00045391-199801000-00006","article-title":"Hepatic encephalopathy and role of antibenzodiazepines","volume":"5","author":"Hammond","year":"1998","journal-title":"Am J Ther"},{"key":"10.1186\/s43141-021-00224-0_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40734-016-0047-6","article-title":"Medical treatment of dystonia","volume":"3","author":"Termsarasab","year":"2016","journal-title":"J Clin Mov Disord"},{"key":"10.1186\/s43141-021-00224-0_bib53","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s11064-016-2101-z","article-title":"The top 5 neurotransmitters from a clinical neurologist\u2019s perspective","volume":"42","author":"Kondziella","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1186\/s43141-021-00224-0_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABA(A) receptor: positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pbb.2019.02.015","article-title":"GABA(B) receptors modulate morphine antinociception: pharmacological and genetic approaches","volume":"180","author":"Pedr\u00f3n","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1186\/s43141-021-00224-0_bib56","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0896-6273(95)90008-X","article-title":"GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis","volume":"15","author":"LoTurco","year":"1995","journal-title":"Neuron"},{"key":"10.1186\/s43141-021-00224-0_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-3806(99)00035-8","article-title":"GABA induces proliferation of immature cerebellar granule cells grown in vitro","volume":"115","author":"Fiszman","year":"1999","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1186\/s43141-021-00224-0_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fncel.2014.00119","article-title":"Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives","volume":"8","author":"Deidda","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nature11306","article-title":"Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision","volume":"489","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1186\/s43141-021-00224-0_bib60","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nn1522","article-title":"Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors","volume":"8","author":"Liu","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib61","doi-asserted-by":"crossref","unstructured":"Song J, Olsen RHJ, Sun J et al (2016) Neuronal circuitry mechanisms regulating adult mammalian neurogenesis. Cold Spring Harb Perspect Biol 8. https:\/\/doi.org\/10.1101\/cshperspect.a018937","DOI":"10.1101\/cshperspect.a018937"},{"key":"10.1186\/s43141-021-00224-0_bib62","first-page":"8","article-title":"GABA(A) Increases calcium in subventricular zone astrocyte-like cells through L- and T-type voltage-gated calcium channels","volume":"4","author":"Young","year":"2010","journal-title":"Front Cell Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fncel.2014.00010","article-title":"GABAergic striatal neurons project dendrites and axons into the postnatal subventricular zone leading to calcium activity","volume":"8","author":"Young","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(02)13011-7","article-title":"GABA and GABA receptors in the central nervous system and other organs","volume":"213","author":"Watanabe","year":"2002","journal-title":"Int Rev Cytol"},{"key":"10.1186\/s43141-021-00224-0_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cmet.2005.11.015","article-title":"Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system","volume":"3","author":"Xu","year":"2006","journal-title":"Cell Metab"},{"key":"10.1186\/s43141-021-00224-0_bib66","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2337\/db14-0153","article-title":"GABA promotes human \u03b2-cell proliferation and modulates glucose homeostasis","volume":"63","author":"Purwana","year":"2014","journal-title":"Diabetes"},{"key":"10.1186\/s43141-021-00224-0_bib67","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.2337\/db13-0931","article-title":"\u03b3-Aminobutyric acid regulates both the survival and replication of human \u03b2-cells","volume":"62","author":"Tian","year":"2013","journal-title":"Diabetes"},{"key":"10.1186\/s43141-021-00224-0_bib68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ebiom.2018.03.014","article-title":"Functional characterization of native, high-affinity GABAA receptors in human pancreatic \u03b2 cells","volume":"30","author":"Korol","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1186\/s43141-021-00224-0_bib69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.apha.2014.11.005","article-title":"Allosteric ligands and their binding sites define \u03b3-aminobutyric acid (GABA) type A receptor subtypes","volume":"73","author":"Olsen","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-4530(84)90032-5","article-title":"Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist","volume":"9","author":"Bartholini","year":"1984","journal-title":"Psychoneuroendocrinology"},{"key":"10.1186\/s43141-021-00224-0_bib71","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1523\/JNEUROSCI.4697-11.2012","article-title":"GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons","volume":"32","author":"Vashchinkina","year":"2012","journal-title":"J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2009.05.008","article-title":"Effects of gamma-aminobutyric acid (GABA) agonists and a GABA uptake inhibitor on pharmacoresistant seizure like events in organotypic hippocampal slice cultures","volume":"86","author":"Wahab","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1186\/s43141-021-00224-0_bib73","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bph.12127","article-title":"Advantages of an antagonist: bicuculline and other GABA antagonists","volume":"169","author":"Johnston","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1748-1716.2006.01617.x","article-title":"Pregnenolone sulphate and Zn2+ inhibit recombinant rat GABA(A) receptor through different channel property","volume":"188","author":"Wang","year":"2006","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1186\/s43141-021-00224-0_bib75","doi-asserted-by":"crossref","unstructured":"Vega Alanis BA, Iorio MT, Silva LL et al (2020) Allosteric GABA(A) receptor modulators-a review on the most recent heterocyclic chemotypes and their synthetic accessibility. Molecules 25. https:\/\/doi.org\/10.3390\/molecules25040999","DOI":"10.3390\/molecules25040999"},{"key":"10.1186\/s43141-021-00224-0_bib76","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.bpj.2011.10.055","article-title":"Cys-loop receptor channel blockers also block GLIC","volume":"101","author":"Alqazzaz","year":"2011","journal-title":"Biophys J"},{"key":"10.1186\/s43141-021-00224-0_bib77","first-page":"641","article-title":"Flumazenil: a benzodiazepine antagonist","volume":"12","author":"Hoffman","year":"1993","journal-title":"Clin Pharm"},{"key":"10.1186\/s43141-021-00224-0_bib78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1186\/s43141-021-00224-0_bib79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/187152708784083812","article-title":"GABAA receptors, anesthetics and anticonvulsants in brain development","volume":"7","author":"Henschel","year":"2008","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1186\/s43141-021-00224-0_bib80","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1186\/s43141-021-00224-0_bib81","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fphys.2014.00160","article-title":"Principles of agonist recognition in Cys-loop receptors","volume":"5","author":"Lynagh","year":"2014","journal-title":"Front Physiol"},{"key":"10.1186\/s43141-021-00224-0_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2017.03.003","article-title":"GABA(A) Receptors and the diversity in their structure and pharmacology","volume":"79","author":"Chua","year":"2017","journal-title":"Adv Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib83","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1523\/JNEUROSCI.23-35-11158.2003","article-title":"Individual properties of the two functional agonist sites in GABA(A) receptors","volume":"23","author":"Baumann","year":"2003","journal-title":"J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052323","article-title":"A unified model of the GABAA receptor comprising agonist and benzodiazepine binding sites","volume":"8","author":"Bergmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1186\/s43141-021-00224-0_bib85","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/jnc.12083","article-title":"Multiple tyrosine residues at the GABA binding pocket influence surface expression and mediate kinetics of the GABAA receptor","volume":"124","author":"Laha","year":"2013","journal-title":"J Neurochem"},{"key":"10.1186\/s43141-021-00224-0_bib86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1186\/s43141-021-00224-0_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","article-title":"Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics","volume":"44","author":"Rudolph","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1186\/s43141-021-00224-0_bib88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0306-4522(03)00288-4","article-title":"Comparative modeling of GABA(A) receptors: limits, insights, future developments","volume":"119","author":"Ernst","year":"2003","journal-title":"Neuroscience"},{"key":"10.1186\/s43141-021-00224-0_bib89","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(98)00803-5","article-title":"Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits","volume":"431","author":"Benson","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1186\/s43141-021-00224-0_bib90","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1186\/s43141-021-00224-0_bib91","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02741459","article-title":"The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes","volume":"18","author":"Hevers","year":"1998","journal-title":"Mol Neurobiol"},{"key":"10.1186\/s43141-021-00224-0_bib93","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1186\/s43141-021-00224-0_bib94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib95","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1021\/acs.jmedchem.6b01332","article-title":"Synthesis and characterization of a novel \u03b3-aminobutyric acid type A (GABA(A)) receptor ligand that combines outstanding metabolic stability, pharmacokinetics, and anxiolytic efficacy","volume":"59","author":"Poe","year":"2016","journal-title":"J Med Chem"},{"key":"10.1186\/s43141-021-00224-0_bib96","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bph.12153","article-title":"Subtype selectivity of \u03b1+\u03b2- site ligands of GABAA receptors: identification of the first highly specific positive modulators at \u03b16\u03b22\/3\u03b32 receptors","volume":"169","author":"Varagic","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib97","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1038\/s41598-017-05757-4","article-title":"Molecular tools for GABA(A) receptors: high affinity ligands for \u03b21-containing subtypes","volume":"7","author":"Simeone","year":"2017","journal-title":"Sci Rep"},{"key":"10.1186\/s43141-021-00224-0_bib98","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm031076j","article-title":"Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers","volume":"47","author":"Sternfeld","year":"2004","journal-title":"J Med Chem"},{"key":"10.1186\/s43141-021-00224-0_bib99","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/ACO.0000000000000358","article-title":"New insights in the systemic and molecular underpinnings of general anesthetic actions mediated by \u03b3-aminobutyric acid A receptors","volume":"29","author":"Antkowiak","year":"2016","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1186\/s43141-021-00224-0_bib100","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol\u2019s amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib101","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1186\/s43141-021-00224-0_bib102","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12630-010-9429-7","article-title":"GABA(A) receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation","volume":"58","author":"Olsen","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1186\/s43141-021-00224-0_bib103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/38738","article-title":"Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors","volume":"389","author":"Mihic","year":"1997","journal-title":"Nature"},{"key":"10.1186\/s43141-021-00224-0_bib104","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1213\/ANE.0000000000001368","article-title":"Mapping general anesthetic sites in heteromeric \u03b3-aminobutyric acid type A receptors reveals a potential for targeting receptor subtypes","volume":"123","author":"Forman","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1186\/s43141-021-00224-0_bib105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12630-010-9419-9","article-title":"Anesthetic sites and allosteric mechanisms of action on Cys-loop ligand-gated ion channels","volume":"58","author":"Forman","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1186\/s43141-021-00224-0_bib106","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157015910790909502","article-title":"General anesthetic actions on GABA(A) receptors","volume":"8","author":"Garcia","year":"2010","journal-title":"Curr Neuropharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib107","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/bi201772m","article-title":"Mapping general anesthetic binding site(s) in human \u03b11\u03b23 \u03b3-aminobutyric acid type A receptors with [3H]TDBzl-etomidate, a photoreactive etomidate analogue","volume":"51","author":"Chiara","year":"2012","journal-title":"Biochemistry"},{"key":"10.1186\/s43141-021-00224-0_bib108","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/mol.112.084558","article-title":"State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor","volume":"83","author":"Stewart","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib109","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1186\/s43141-021-00224-0_bib110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/mol.115.100347","article-title":"Mutational analysis of the putative high-affinity propofol binding site in human \u03b23 homomeric GABAA receptors","volume":"88","author":"Eaton","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib111","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/ALN.0000000000000588","article-title":"Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian \u03b3-aminobutyric acid type A receptors","volume":"122","author":"Franks","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1186\/s43141-021-00224-0_bib112","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nchembio.1340","article-title":"A propofol binding site on mammalian GABAA receptors identified by photolabeling","volume":"9","author":"Yip","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1186\/s43141-021-00224-0_bib113","first-page":"250","article-title":"General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit","volume":"17","author":"Jurd","year":"2003","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"10.1186\/s43141-021-00224-0_bib114","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.23-24-08608.2003","article-title":"Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms","volume":"23","author":"Reynolds","year":"2003","journal-title":"J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1476-5381.1996.tb15221.x","article-title":"Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination","volume":"117","author":"Thompson","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.01.003","article-title":"Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital","volume":"105","author":"Maldifassi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib117","doi-asserted-by":"crossref","first-page":"26529","DOI":"10.1074\/jbc.M116.753335","article-title":"General anesthetic binding sites in human \u03b14\u03b23\u03b4 \u03b3-aminobutyric acid type A receptors (GABAARs)","volume":"291","author":"Chiara","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1186\/s43141-021-00224-0_bib118","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib119","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1124\/mol.108.048520","article-title":"Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids","volume":"74","author":"Akk","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1186\/s43141-021-00224-0_bib121","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1476-5381.2009.00390.x","article-title":"Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation","volume":"158","author":"Li","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABA(A) receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1186\/s43141-021-00224-0_bib123","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/bs.apha.2014.10.007","article-title":"Interactions of flavonoids with ionotropic GABA receptors","volume":"72","author":"Hanrahan","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib124","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.2011.01228.x","article-title":"Flavonoid modulation of GABA(A) receptors","volume":"163","author":"Hanrahan","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib125","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/JCM.40.10.3613-3619.2002","article-title":"Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR","volume":"40","author":"Wang","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1186\/s43141-021-00224-0_bib126","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neuropharm.2008.06.069","article-title":"Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice","volume":"55","author":"Fernandez","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib127","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neuropharm.2007.06.018","article-title":"6,2\u2019-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site","volume":"53","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib128","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0705828","article-title":"The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects","volume":"142","author":"Kavvadias","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib130","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/epi.14574","article-title":"A novel GABAergic dysfunction in human Dravet syndrome","volume":"59","author":"Ruffolo","year":"2018","journal-title":"Epilepsia"},{"key":"10.1186\/s43141-021-00224-0_bib131","doi-asserted-by":"crossref","unstructured":"An D, Peigneur S, Hendrickx LA, Tytgat J (2020) Targeting cannabinoid receptors: current status and prospects of natural products. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21145064","DOI":"10.3390\/ijms21145064"},{"key":"10.1186\/s43141-021-00224-0_bib132","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1021\/jm058183t","article-title":"The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications","volume":"48","author":"Lambert","year":"2005","journal-title":"J Med Chem"},{"key":"10.1186\/s43141-021-00224-0_bib133","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib134","doi-asserted-by":"crossref","first-page":"18150","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABA(A) receptors","volume":"108","author":"Sigel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1186\/s43141-021-00224-0_bib135","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.7717\/peerj.149","article-title":"Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the \u03b22 subunit of GABAA receptors?","volume":"1","author":"Baur","year":"2013","journal-title":"PeerJ"},{"key":"10.1186\/s43141-021-00224-0_bib136","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/cercor\/bhu045","article-title":"Control of inhibition by the direct action of cannabinoids on GABAA receptors","volume":"25","author":"Golovko","year":"2015","journal-title":"Cereb Cortex"},{"key":"10.1186\/s43141-021-00224-0_bib137","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1021\/jacs.0c05042","article-title":"Synthesis of (-)-picrotoxinin by late-stage strong bond activation","volume":"142","author":"Crossley","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1186\/s43141-021-00224-0_bib138","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1021\/acs.orglett.9b01806","article-title":"Synthesis of the tricyclic picrotoxane motif by an oxidative cascade cyclization","volume":"21","author":"Cao","year":"2019","journal-title":"Org Lett"},{"key":"10.1186\/s43141-021-00224-0_bib139","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.0954-6820.1950.tb12129.x","article-title":"On treatment of barbiturate poisoning","volume":"137","author":"Nilsson","year":"1950","journal-title":"Acta Med Scand"},{"key":"10.1186\/s43141-021-00224-0_bib140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(98)00661-X","article-title":"[3H]t-butylbicycloorthobenzoate binding to recombinant alpha1beta2gamma2s GABA(A) receptor","volume":"360","author":"Perici\u0107","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib141","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuint.2006.07.004","article-title":"Mapping convulsants\u2019 binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites","volume":"50","author":"Kalueff","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1186\/s43141-021-00224-0_bib142","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.2174\/1381612821666150914121624","article-title":"GABA receptors: pharmacological potential and pitfalls","volume":"21","author":"Jembrek","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1186\/s43141-021-00224-0_bib143","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1113\/jphysiol.2011.213249","article-title":"Influences on blockade by t-butylbicyclo-phosphoro-thionate of GABA(A) receptor spontaneous gating, agonist activation and desensitization","volume":"590","author":"Othman","year":"2012","journal-title":"J Physiol"},{"key":"10.1186\/s43141-021-00224-0_bib144","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib145","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","article-title":"Pharmacological characterization of agonists at delta-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2","volume":"316","author":"St\u00f3rustovu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1186\/s43141-021-00224-0_bib146","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bph.12001","article-title":"A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors","volume":"168","author":"Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib147","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.yebeh.2009.02.036","article-title":"Curing epilepsy: progress and future directions","volume":"14","author":"Jacobs","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1186\/s43141-021-00224-0_bib148","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/epi.12056","article-title":"Research implications of the Institute of Medicine report, epilepsy across the spectrum: promoting health and understanding","volume":"54","author":"Hesdorffer","year":"2013","journal-title":"Epilepsia"},{"key":"10.1186\/s43141-021-00224-0_bib149","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1186\/s43141-021-00224-0_bib150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.conb.2013.11.004","article-title":"GABA actions and ionic plasticity in epilepsy","volume":"26","author":"Kaila","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"10.1186\/s43141-021-00224-0_bib151","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.2174\/1381612823666170809100230","article-title":"Modulation of GABAA receptors in the treatment of epilepsy","volume":"23","author":"Palma","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1186\/s43141-021-00224-0_bib152","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/JEP.S242964","article-title":"Experimental GABA A receptor agonists and allosteric modulators for the treatment of focal epilepsy","volume":"13","author":"Jankovi\u0107","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib153","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","article-title":"The GABAA receptor as a therapeutic target for neurodevelopmental disorders","volume":"86","author":"Braat","year":"2015","journal-title":"Neuron"},{"key":"10.1186\/s43141-021-00224-0_bib154","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-444-63326-2.00003-X","article-title":"Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy","volume":"213","author":"Hirose","year":"2014","journal-title":"Prog Brain Res"},{"key":"10.1186\/s43141-021-00224-0_bib155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fncel.2019.00077","article-title":"Alterations in GABA(A)-receptor trafficking and synaptic dysfunction in brain disorders","volume":"13","author":"Mele","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib156","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nn.4024","article-title":"The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration","volume":"18","author":"Kang","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib157","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.15252\/emmm.201708525","article-title":"Simultaneous impairment of neuronal and metabolic function of mutated gephyrin in a patient with epileptic encephalopathy","volume":"9","author":"Dejanovic","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1186\/s43141-021-00224-0_bib158","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/emm.2015.5","article-title":"Gephyrin: a central GABAergic synapse organizer","volume":"47","author":"Choii","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1186\/s43141-021-00224-0_bib159","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/syn.20928","article-title":"Downregulation of gephyrin in temporal lobe epilepsy neurons in humans and a rat model","volume":"65","author":"Fang","year":"2011","journal-title":"Synapse"},{"key":"10.1186\/s43141-021-00224-0_bib160","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1021\/cr3000994","article-title":"The amyloid beta peptide: a chemist\u2019s perspective. Role in Alzheimer\u2019s and fibrillization","volume":"112","author":"Hamley","year":"2012","journal-title":"Chem Rev"},{"key":"10.1186\/s43141-021-00224-0_bib161","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fnins.2020.00660","article-title":"GABAergic inhibitory interneuron deficits in Alzheimer\u2019s disease: implications for treatment","volume":"14","author":"Xu","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib162","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.1186\/s43141-021-00224-0_bib163","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/mp.2008.66","article-title":"Strong genetic evidence for a selective influence of GABA A receptors on a component of the bipolar disorder phenotype","volume":"15","author":"Craddock","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1186\/s43141-021-00224-0_bib164","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuron.2017.11.028","article-title":"Alzheimer\u2019s disease: from firing instability to homeostasis network collapse","volume":"97","author":"Frere","year":"2018","journal-title":"Neuron"},{"key":"10.1186\/s43141-021-00224-0_bib165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.aay5188","article-title":"Early network dysfunction in Alzheimer\u2019s disease","volume":"365","author":"Selkoe","year":"2019","journal-title":"Science"},{"key":"10.1186\/s43141-021-00224-0_bib166","doi-asserted-by":"crossref","unstructured":"Govindpani K, Turner C, Waldvogel HJ et al (2020) Impaired expression of GABA signaling components in the Alzheimer\u2019s disease middle temporal gyrus. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21228704","DOI":"10.3390\/ijms21228704"},{"key":"10.1186\/s43141-021-00224-0_bib167","first-page":"1575","article-title":"Alzheimer\u2019s disease: amino acid levels and brain metabolic status","volume":"34","author":"Gueli","year":"2013","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1186\/s43141-021-00224-0_bib168","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archneur.1982.00510230035010","article-title":"Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer\u2019s disease. Age- or disease-related modifications?","volume":"39","author":"Bareggi","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1186\/s43141-021-00224-0_bib169","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(98)00698-3","article-title":"Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele","volume":"255","author":"Grouselle","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1186\/s43141-021-00224-0_bib170","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABA(A) receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1186\/s43141-021-00224-0_bib171","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jnr.23244","article-title":"Baicalein reduces \u03b2-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer\u2019s disease transgenic mouse model","volume":"91","author":"Zhang","year":"2013","journal-title":"J Neurosci Res"},{"key":"10.1186\/s43141-021-00224-0_bib172","doi-asserted-by":"crossref","unstructured":"Defazio G, Jankovic J, Giel JL, Papapetropoulos S (2013) Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov 3. https:\/\/doi.org\/10.7916\/D80C4TGJ","DOI":"10.5334\/tohm.170"},{"key":"10.1186\/s43141-021-00224-0_bib173","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/mds.25567","article-title":"The focal dystonias: current views and challenges for future research","volume":"28","author":"Jinnah","year":"2013","journal-title":"Mov Disord"},{"key":"10.1186\/s43141-021-00224-0_bib174","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2014.09.002","article-title":"Diagnosis and treatment of dystonia","volume":"33","author":"Jinnah","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1186\/s43141-021-00224-0_bib175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fneur.2018.00188","article-title":"GABA(A) Receptor availability changes underlie symptoms in isolated cervical dystonia","volume":"9","author":"Berman","year":"2018","journal-title":"Front Neurol"},{"issue":"1245","key":"10.1186\/s43141-021-00224-0_bib176","article-title":"Multiple changes of functional connectivity between sensorimotor areas in focal hand dystonia","volume":"85","author":"Dresel","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1186\/s43141-021-00224-0_bib177","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1460-9568.2000.00999.x","article-title":"Bicuculline injections into the rostral and caudal motor thalamus of the monkey induce different types of dystonia","volume":"12","author":"Guehl","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib178","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fneur.2020.575879","article-title":"Cervical dystonia is associated with aberrant inhibitory signaling within the thalamus","volume":"11","author":"Groth","year":"2021","journal-title":"Front Neurol"},{"key":"10.1186\/s43141-021-00224-0_bib179","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09511","article-title":"Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke","volume":"468","author":"Clarkson","year":"2010","journal-title":"Nature"},{"key":"10.1186\/s43141-021-00224-0_bib180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11011-014-9560-1","article-title":"GABA receptors in brain development, function, and injury","volume":"30","author":"Wu","year":"2015","journal-title":"Metab Brain Dis"},{"key":"10.1186\/s43141-021-00224-0_bib181","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12974-014-0189-0","article-title":"GABAergic\/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders","volume":"11","author":"El-Ansary","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1186\/s43141-021-00224-0_bib182","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/297153","article-title":"Alterations of GABAergic signaling in autism spectrum disorders","volume":"2011","author":"Pizzarelli","year":"2011","journal-title":"Neural Plast"},{"key":"10.1186\/s43141-021-00224-0_bib183","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2012.04.008","article-title":"The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study","volume":"68","author":"Mendez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib184","doi-asserted-by":"crossref","unstructured":"Horder J, Andersson M, Mendez MA et al (2018) GABA(A) receptor availability is not altered in adults with autism spectrum disorder or in mouse models. Sci Transl Med 10. https:\/\/doi.org\/10.1126\/scitranslmed.aam8434","DOI":"10.1126\/scitranslmed.aam8434"},{"key":"10.1186\/s43141-021-00224-0_bib185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-018-1073-7","article-title":"Meta-analysis of the association between GABA receptor polymorphisms and autism spectrum disorder (ASD)","volume":"65","author":"Mahdavi","year":"2018","journal-title":"J Mol Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib186","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41537-020-0093-9","article-title":"Post-translational protein modifications in schizophrenia","volume":"6","author":"Mueller","year":"2020","journal-title":"NPJ Schizophr"},{"key":"10.1186\/s43141-021-00224-0_bib187","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1038\/s41380-020-0761-1","article-title":"Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies","volume":"25","author":"Williams","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1186\/s43141-021-00224-0_bib188","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1038\/tp.2015.102","article-title":"Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain","volume":"5","author":"Mueller","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.1186\/s43141-021-00224-0_bib189","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/npp.2013.190","article-title":"N-Glycosylation of GABAA receptor subunits is altered in schizophrenia","volume":"39","author":"Mueller","year":"2014","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib190","doi-asserted-by":"crossref","unstructured":"Marques TR, Ashok AH, Angelescu I et al (2020) GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-020-0711-y","DOI":"10.1038\/s41380-020-0711-y"},{"key":"10.1186\/s43141-021-00224-0_bib191","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2019.00087","article-title":"Cortical GABAergic Dysfunction in stress and depression: new insights for therapeutic interventions","volume":"13","author":"Foga\u00e7a","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1186\/s43141-021-00224-0_bib192","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5607\/en.2017.26.3.122","article-title":"Altered GABAergic signaling in brain disease at various stages of life","volume":"26","author":"Kim","year":"2017","journal-title":"Exp Neurobiol"},{"key":"10.1186\/s43141-021-00224-0_bib193","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00213-017-4670-1","article-title":"Regulation of sustained attention, false alarm responding and implementation of conditional rules by prefrontal GABA(A) transmission: comparison with NMDA transmission","volume":"234","author":"Auger","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112261","article-title":"Contribution of GABA(A) receptor subunits to attention and social behavior","volume":"378","author":"Paine","year":"2020","journal-title":"Behav Brain Res"},{"key":"10.1186\/s43141-021-00224-0_bib195","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/npp.2011.51","article-title":"Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors","volume":"36","author":"Paine","year":"2011","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1186\/s43141-021-00224-0_bib196","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuropharm.2012.09.009","article-title":"Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task","volume":"65","author":"Asinof","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib197","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00213-012-2792-z","article-title":"The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention","volume":"225","author":"Pehrson","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1186\/s43141-021-00224-0_bib198","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbr.2016.10.012","article-title":"Decreasing GABA function within the medial prefrontal cortex or basolateral amygdala decreases sociability","volume":"317","author":"Paine","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1186\/s43141-021-00224-0_bib199","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuropharm.2015.10.007","article-title":"Perturbations in reward-related decision-making induced by reduced prefrontal cortical GABA transmission: relevance for psychiatric disorders","volume":"101","author":"Piantadosi","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00224-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43141-021-00224-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23006595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23006595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00224-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:05:11Z","timestamp":1761660311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X23006595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":199,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1687157X23006595"],"URL":"https:\/\/doi.org\/10.1186\/s43141-021-00224-0","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GABAA receptors: structure, function, pharmacology, and related disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s43141-021-00224-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Academy of Scientific Research and Technology. Published by Elsevier BV.","name":"copyright","label":"Copyright"}],"article-number":"123"}}